Literature DB >> 12743315

Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

Bianca Heemskerk1, Louise A Veltrop-Duits, Tamara van Vreeswijk, Monique M ten Dam, Sebastiaan Heidt, Rene E M Toes, Maarten J D van Tol, Marco W Schilham.   

Abstract

Adenovirus (Ad)-specific T-cell responses in healthy adult donors were investigated. Ad5, inactivated by methylene blue plus visible light, induced proliferation and gamma interferon (IFN-gamma) production in peripheral blood mononuclear cells of the majority of donors. Responding T cells were CD4(+) and produced IFN-gamma upon restimulation with infectious Ad5 and Ads of different subgroups. T-cell clones showed distinct cross-reactivity patterns recognizing Ad serotypes from either one subgroup (C), two subgroups (B and C), or three subgroups (A, B, and C). This cross-reactivity of Ad-specific T cells has relevance both for Ad-based gene therapy protocols, as well as for the feasibility of T-cell-mediated adoptive immunotherapy in recipients of an allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743315      PMCID: PMC155022          DOI: 10.1128/jvi.77.11.6562-6566.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Adoptive cellular immunotherapy for EBV lymphoproliferative disease.

Authors:  H E Heslop; C M Rooney
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

2.  Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation.

Authors:  M Kawakami; S Ueda; T Maeda; T Karasuno; H Teshima; A Hiraoka; H Nakamura; K Tanaka; T Masaoka
Journal:  Bone Marrow Transplant       Date:  1997-09       Impact factor: 5.483

3.  Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.

Authors:  F H Schagen; A C Moor; S C Cheong; S J Cramer; H van Ormondt; A J van der Eb; T M Dubbelman; R C Hoeben
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

4.  Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity.

Authors:  H Aihara; T Takasaki; T Matsutani; R Suzuki; I Kurane
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Virus inactivation of blood products by phenothiazine dyes and light.

Authors:  H Mohr; B Bachmann; A Klein-Struckmeier; B Lambrecht
Journal:  Photochem Photobiol       Date:  1997-03       Impact factor: 3.421

6.  High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.

Authors:  R Childs; C Sanchez; H Engler; J Preuss; S Rosenfeld; C Dunbar; F van Rhee; M Plante; S Phang; A J Barrett
Journal:  Bone Marrow Transplant       Date:  1998-11       Impact factor: 5.483

7.  Extensive cross-reactivity of adenovirus-specific cytotoxic T cells.

Authors:  C A Smith; L S Woodruff; C Rooney; G R Kitchingman
Journal:  Hum Gene Ther       Date:  1998-07-01       Impact factor: 5.695

8.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.

Authors:  L Crawford-Miksza; D P Schnurr
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma.

Authors:  K Müller-Breitkreutz; H Mohr
Journal:  J Med Virol       Date:  1998-11       Impact factor: 2.327

10.  Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

Authors:  J B Haanen; M C Wolkers; A M Kruisbeek; T N Schumacher
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  27 in total

1.  Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.

Authors:  Maaike E Ressing; Daphne van Leeuwen; Frank A W Verreck; Raquel Gomez; Bianca Heemskerk; Mireille Toebes; Maureen M Mullen; Theodore S Jardetzky; Richard Longnecker; Marco W Schilham; Tom H M Ottenhoff; Jacques Neefjes; Ton N Schumacher; Lindsey M Hutt-Fletcher; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

2.  Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.

Authors:  Shawn M Sumida; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Shawn S Jackson; Darci A Gorgone; Michelle A Lifton; Wouter Koudstaal; Maria G Pau; Stefan Kostense; Menzo J E Havenga; Jaap Goudsmit; Norman L Letvin; Dan H Barouch
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.

Authors:  Angelique A C Lemckert; Shawn M Sumida; Lennart Holterman; Ronald Vogels; Diana M Truitt; Diana M Lynch; Anjali Nanda; Bonnie A Ewald; Darci A Gorgone; Michelle A Lifton; Jaap Goudsmit; Menzo J E Havenga; Dan H Barouch
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

Authors:  Masahiko Hashimoto; Julie L Boyer; Neil R Hackett; James M Wilson; Ronald G Crystal
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus.

Authors:  Matthieu Perreau; Eric J Kremer
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 8.  Adenovirus DNA replication.

Authors:  Rob C Hoeben; Taco G Uil
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

Review 9.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.